The Hamburg Cancer Registry regularly evaluates data on cancer incidence in the Hamburg resident population and on oncological care in the Hanseatic City. The results are published interactively online as annual report (residence-based) and annual report (treatment and facility-location-based). In addition, the HCR participates in national and international reporting as well as in research projects and scientific publications. Under "Use of data" you will find information on how to request data from the HKR.
Residence-based data and reports
Data query: Figures on new cases from 1995 onwards and deaths from 2002 onwards in Hamburg's resident population make possible longer time series.
Interactive annual report (based on place of residence): Information on new cases, mortality and prevalence in the resident population of Hamburg for a 10-year period is prepared in the form of graphs, tables and small-scale maps for the most common tumour entities. Current evaluations on the survival of cancer patients as well as information on tumour characteristics, reporting origin and methodology complete the report.
Hamburg Cancer Documentation 2016-2018: The print or PDF report provides an overview of cancer incidence in the population as well as the history and current work of the Hamburg Cancer Registry.
Chapter overviewTreatment and facility-related report
Interactive annual report (based on treatment location): The evaluations refer to all persons receiving oncological care in Hamburg, regardless of their place of residence. In addition to information on case numbers, age distribution, tumour data, metastasis and therapy, the quality of the reports overall as well as in comparison of the reporting Hospitals and practices is the subject of this report.
Cancer reporting nationally and internationally
The Hamburg data on cancer are also included in nationally and internationally published evaluations and publications:
- Cancer in Germany 2017/2018 (Report)
- Database query of the Centre for Cancer Registry Data at the Robert Koch Institute (data query)
- GEKID Atlas (Interactive Report)
- GEKID county atlas (incidence 2010-2014 at county level)
- GEKID Survival Atlas (survival 2013-2015 at county level)
- ECIS – European Cancer Information System (Interactive Report)
- Global Cancer Observatory (Interactive Report)
- Cancer Incidence in Five Continents (Interactive Report)
Scientific publications
2023
Schultz A, Kraywinkel K, Peters F (2023) Faktenblatt: Epidemiologie des Endometriumkarzinoms in Deutschland 2009 bis 2019. Onkologie 29:391–395, doi:10.1007/s00761-023-01339-4
Thong MSY, Doege D, Weißer L, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Brenner H, Arndt V (2023) Persisting deficits in health-related quality of life of colorectal cancer survivors 14–24 years post-diagnosis: a population-based study. Curr Oncol 30(3):3373–3390, doi:10.3390/curroncol30030257
2022
Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V (2022) Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors. J Cancer Res Clin Oncol (2022), doi:10.1007/s00432-022-04204-w
Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond D, Bulliard J-L, Girardi F, Fowler C, Marcos-Gragera R, Bonaventure A, Saint-Jacques N, CONCORD Working Group, et al. (2022) Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health 6(6): 409–431, doi:10.1016/S2352-4642(22)00095-5
Pigeot I, Bongaerts B, Eberle A, Katalinic A, Kieschke J, Luttmann S, Meyer M, Nennecke A, Rathmann W, Stabenow R, Wilsdorf-Köhler H, Kollhorst B, Reinders T (2022) Verknüpfung von Abrechnungsdaten gesetzlicher Krankenkassen mit Daten epidemiologischer Krebsregister: länderspezifische Möglichkeiten und Limitationen. Bundesgesundheitsbl 65(5):615–623, doi:10.1007/s00103-021-03475-x
Thong MSY, Doege D, Weißer L, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Schlander M, Brenner H, Arndt V (2022) Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study. J Cancer Res Clin Oncol 148(1):155–162, doi:10.1007/s00432-021-03825-x
2021
Doege D, Thong MS, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Nennecke A, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V (2021) Depression und subjektive kognitive Beeinträchtigung bei Langzeit-Brustkrebsüberlebenden. Gynakol Prax 48(1):22–30
Liu Z, Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeißig SR, Pritzkuleit R, Arndt V (2021) Distress mediates the relationship between cognitive appraisal of medical care and benefit finding/posttraumatic growth in long-term cancer survivors. Cancer 127(19):3680–3690, doi:10.1002/cncr.33684
Doege D, Thong MSY, Weißer L, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Nennecke A, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V (2021) Health-related quality of life in very long-term cancer survivors 14–24 years post-diagnosis compared to population controls: a population-based study. Cancers 13(11):2754, doi:10.3390/cancers13112754
Liu Z, Thong MSY, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldmann A, Zeissig SR, Pritzkuleit R, Brenner H, Arndt V (2021) Prevalence of benefit finding and posttraumatic growth in long-term cancer survivors: results from a multi-regional population-based survey in Germany. Br J Cancer 125(6):877–883, doi:10.1038/s41416-021-01473-z
Jansen L, Erb C, Nennecke A, Finke I, Pritzkuleit R, Holleczek B, Brenner H (2021) Socioeconomic deprivation and cancer survival in a metropolitan area: An analysis of cancer registry data from Hamburg, Germany. Lancet Reg Health Eur 4:100063, doi:10.1016/j.lanepe.2021.100063
Jansen L, Kanbach J, Finke I, Arndt V, Emrich K, Holleczek B, Kajuter H, Kieschke J, Maier W, Pritzkuleit R, Sirri E, Schwettmann L, Erb C, Brenner H, Group ftGCSW (2021) Estimation of the potentially avoidable excess deaths associated with socioeconomic inequalities in cancer survival in Germany. Cancers:13(2):357, doi:10.3390/cancers13020357
Jansen L, Moratin J, Waldmann A, Zaoui K, Holleczek B, Nennecke A, Pritzkuleit R, Plinkert PK, Hoffmann J, Arndt V (2021) Mundhöhlen- und Pharynxkarzinome: Inzidenz, Mortalität und Überleben in Deutschland. Bundesgesundheitsbl 64:941–950, doi:10.1007/s00103-021-03368-z
2020
Hübner J, Katalinic A, Waldmann A, Kraywinkel K. Long-term incidence and mortality trends for breast cancer in Germany (2020) Geburtshilfe Frauenheilkd 80(6):611–618, doi:10.1055/a-1160-5569
Sirri E, Kieschke J, Vohmann C, Katalinic A, Nennecke A, Ressing M, Eberle A, Holleczek B, Jansen L, Brenner H; GEKID Cancer Survival Working Group (2020) Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: a population-based study. Int J Cancer 147(6):1548–1558, doi:10.1002/ijc.32931
Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schröder CC, Eberle A, Emrich K, Kajüter H, Katalinic A, Kieschke J, Nennecke A, Sirri E, Heil J, Schneeweiss A, Brenner H (2020) Divergent patterns and trends in breast cancer incidence, mortality and survival among older women in Germany and the United States. Cancers 12(9):2419, doi:10.3390/cancers12092419
Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A (2020) Data from population-based cancer registration for secondary data analysis: methodological challenges and perspectives. Gesundheitswesen 82(S 01): 62–71, doi: 10.1055/a-1009-6466
Nennecke A, Waldmann A, Hentschel S (2020) Qualitätssicherung durch Versorgungstransparenz. Hamburger Ärzteblatt 02(2020):28–29
2019
Adam S, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Rohrmann S, Brenner H, Arndt V (2019) Health-related quality of life in long-term survivors with localised prostate cancer by therapy – results from a population-based study. Eur J Cancer Care 28(5):e13076, doi:10.1111/ecc.13076
Arndt V, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Doege D, Thong MSY, Brenner H (2019) Return to work after cancer. A multi-regional population-based study from Germany. Acta Oncol 58(5):811–818. doi:10.1080/0284186X.2018.1557341
Buttmann-Schweiger N, Barinoff J, Waldmann A, Barnes B, Kraywinkel K (2019) Epidemiologie der Krebserkrankungen von Vulva und Vagina in Deutschland. Der Onkologe 25(5): 396–403, doi:10.1007/s00761-019-0565-6
Doege D, Thong MS, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Jansen L, Brenner H, Arndt V (2019) Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany. Breast Cancer Res Treat 175(2): 499–510, doi:10.1007/s10549-019-05188-x
Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V (2019) Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls – a population-based study. Acta Oncol 58(5): 801–810, doi:10.1080/0284186X.2018.1557340
2018
Allemani C., T. Matsuda, V. Di Carlo, et al. and CONCORD Working Group (2018): Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391(10125):1023-1075, doi:10.1016/S0140-6736(17)33326-3
Nennecke A, Waldmann A, Hentschel S, Fehr R (2018) Hamburgisches Krebsregister. In: Fehr R, Trojan A (Hg) Nachhaltige StadtGesundheit Hamburg. Bestandsaufnahme und Perspektiven. München: oekom verlag, 106–111, doi:10.14512/9783962384845
Chapter overviewUse of cancer registry data in research
Aggregated data and anonymized individual data may be provided by the HCR, in particular for the purposes of scientific research and for assessing the quality of oncological care (§§ 7 and 8 HmbKrebsRG).
At the request of universities, scientific institutes and other public institutions, personal data may also be provided under certain conditions (cf. § 9 HmbKrebsRG). This enables e.g. to specifically interview cancer patients or ask them to participate in special research projects. Different application forms are available (only in German) for the corresponding data formats:
Provision of aggregated data
Provision of anonymised individual data
Provision of personal data
Please contact the HCR before submitting an application. We will also be happy to answer any questions you may have.
Phone +4940 428 37-2211
E-mail HamburgischesKrebsregister@bwfgb.hamburg.de
Current information
The Hamburg Cancer Registry informs about four times a year about further developments of the comprehensive clinical cancer registration in Hamburg with a newsletter (German only). The newsletter can be subscribed via the following link.
Newsletter 2020–2022